SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMYLIN PHARM.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael Collins who wrote (8)10/1/1996 5:38:00 PM
From: Michael Collins   of 52
 
Come on, I know there has to be somebody out there who has
a comment on Amylin!!!! If so, what is it??? Talked to Sturza's
Investment Letter and they were positive about the stock for the
short-term (the announcement of Phase III results for the second
half of '97 on Pramlintide - if good, and they believe they will be,
they think the stock is a double from current levels.) They were,
however, concerned about long-term possibilities for the drug (didn't
get into that as I am only focused on the short-term). I think the stock
is a triple from current levels if the announcement in the second half
is good! There is risk, of course, with any biotech but this one has
a good chance, in my opinion! Any other opinions are welcomed!

Michael Collins
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext